Basit öğe kaydını göster

dc.contributor.authorYenidunya, G.
dc.contributor.authorBekpinar, S.
dc.contributor.authorDinccag, N.
dc.contributor.authorAycan-Ustyol, E.
dc.contributor.authorGurdol, F.
dc.contributor.authorUnlucerci, Y.
dc.date.accessioned2021-03-06T21:09:15Z
dc.date.available2021-03-06T21:09:15Z
dc.date.issued2015
dc.identifier.citationBekpinar S., Yenidunya G., Gurdol F., Unlucerci Y., Aycan-Ustyol E., Dinccag N., "The effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes", CLINICAL BIOCHEMISTRY, cilt.48, ss.1264-1267, 2015
dc.identifier.issn0009-9120
dc.identifier.otherav_fd6da283-90dd-459c-8e2e-184950a7dde7
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/165790
dc.identifier.urihttps://doi.org/10.1016/j.clinbiochem.2015.08.001
dc.description.abstractObjectives: Sphingosine 1-phosphate (S1P) is carried in plasma by the HDL particles and albumin. It mediates several protective functions of HDL. Because of its barrier-enhancing effect, it has attracted attention in diseases associated with endothelial dysfunction. We examined the impact of circulating levels of S1P in diabetic nephropathy together with apoprotein M, a S1P-binding protein in HDL. Plasma levels of dimethylarginines were evaluated in this context.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleThe effect of nephropathy on plasma sphingosine 1-phosphate concentrations in patients with type 2 diabetes
dc.typeMakale
dc.relation.journalCLINICAL BIOCHEMISTRY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume48
dc.identifier.issue18
dc.identifier.startpage1264
dc.identifier.endpage1267
dc.contributor.firstauthorID226484


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster